Vicor Technologies Issued Australian Patent for Its Altered State Physiology Drug Development Platform (Marketwire)
Vicor Technologies Issued Australian Patent for Its Altered State Physiology Drug Development Platform (Marketwire)
BOCA RATON, FL–(Marketwire – September 29, 2009) – David H. Fater, CEO of Vicor Technologies, Inc. ( OTCBB : VCRT ), today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical …